Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Expected to Grow Between 2025 And 2029?
The market size of endoscopic retrograde cholangiopancreatography (ERCP) has been on a solid growth trajectory in recent years. There’s a forecasted expansion from the market value of $1.72 billion in 2024 to $1.86 billion in 2025, marking a compound annual growth rate (CAGR) of 8.4%. The historical growth in this segment owes to several factors, including the increased incidence of chronic gastrointestinal conditions, the more frequent use of ERCP, an uptick in cases of pancreatic cancer, along with greater governmental investment and a surge in medical tourism.
Anticipated robust growth is on the horizon for the Endoscopic Retrograde Cholangiopancreatography (ERCP) market, as projections show an increase to a worth of $2.58 billion by 2029, experiencing a Compound Annual Growth Rate (CAGR) of 8.5%. This uptrend during the forecast period is primarily due to the amplified occurrences of gastrointestinal disorders, rising cancer cases, heightened focus on investing in this domain, an uptick in pancreatic duct incidences, and a surging demand for endoscopes. Key trends observed during this forecast period will be technological progression, collaborative R&D partnerships, enhancement of healthcare infrastructure, enlargement of state healthcare services, and the introduction of sophisticated products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?
The escalating occurrence of gastrointestinal conditions is predicted to fuel the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market in the future. The term gastrointestinal conditions encompass various disorders or diseases impacting the gastrointestinal (GI) tract, such as the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, anus, and the related organs like the liver, gallbladder, and pancreas. The heightened occurrence of these conditions can be traced back to a variety of factors, such as changes in diet, an aged demographic, the use of antibiotics, lifestyle determinants, and environmental impacts. ERCP offers a less invasive solution for diagnosing and treating problems within the bile and pancreatic ducts, such as gallstones, strictures, tumors, or infections in patients suffering from gastrointestinal conditions. For instance, the American Cancer Society, a non-profit organization based in the US, projected that in January 2024, approximately 26,890 new instances of stomach cancer would be recorded in the United States, with an expected 10,880 fatalities from this form of cancer. Consequently, the escalating occurrence of gastrointestinal conditions is propelling the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market.
Which Key Market Segments Comprise the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market and Drive Its Revenue Growth?
The endoscopic retrograde cholangiopancreatography (ercp)market covered in this report is segmented –
1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett’s Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn’s Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20770&type=smp
Which Areas Are Leading Regions in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Expansion Across the Globe?
North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theEndoscopic Retrograde Cholangiopancreatography (ERCP) Market Over the Coming Years?
Key players in the ERCP market are turning their focus towards the creation of novel technologies like the cholangioscope direct visualisation system, a tool aimed at offering advanced and high-definition visualisation capabilities specific to the bile and pancreatic ducts. This system is essentially a medical implement capable of providing high-definition imaging of these ducts during ERCP procedures. An example of this was in July 2024, when a UK-based medical devices firm, Penlon Limited, launched their own version of this system, the VedVision Cholangioscope Direct Visualisation System, optimised for use during ERCP procedures. The device is designed for high-resolution, direct visualization of the bile and pancreatic ducts, improving diagnosis and therapeutic intervention. Notably, it is equipped with a 2 mm accessory channel alongside a dedicated guidewire channel, offering secure access with additional support gained from a comprehensive variety of accessories which include biopsy forceps, stone extraction baskets, cytology brushes and polypectomy snares.
View the full report here:
How Is the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Conceptually Defined?
Endoscopic retrograde cholangiopancreatography (ERCP) is a medical procedure that combines endoscopy and X-ray imaging to diagnose and treat conditions affecting the bile ducts, gallbladder, and pancreas. It involves guiding a flexible, lighted tube (endoscope) through the mouth to the small intestine, allowing physicians to examine these organs and address issues such as blockages or stones.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20770
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model